Saratoga Health & Biotechnology Fund EXEL Holdings History
Saratoga Health & Biotechnology Fund's Exelixis Inc Holding Summary
As of 2025-02-28, Saratoga Health & Biotechnology Fund held 12,368.00 shares of Exelixis Inc(EXEL), totaling $478,520.00. This investment constitutes 4.58% of their stock portfolio, and Saratoga Health & Biotechnology Fund now holds 0% of the outstanding Exelixis Inc(EXEL) stock.
The initial trade took place in 2020Q4. And since then Saratoga Health & Biotechnology Fund has made 3 purchases of EXEL, at an average price of $19.16, for a total of 34,297.00 shares. In addition, there have been 2 sales at an average price of $20.80 for 21,929.00 shares. Based on historical transaction data and EXEL's current price of $44.81, Saratoga Health & Biotechnology Fund's estimated gain on his EXEL holdings is $353,138.82, reflecting a 53.73% gain to date.
Saratoga Health & Biotechnology Fund EXEL ($44.81) Holding Chart
Saratoga Health & Biotechnology Fund EXEL ($44.81) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
